机构

• 上海药物研究所 [124]
• 合肥物质科学研究... [109]
• 上海生物化学与细胞... [27]
• 近代物理研究所 [25]
• 自动化研究所 [21]
• 昆明动物研究所 [17]
• 更多

采集方式

• OAI收割 [429]
• iSwitch采集 [8]

内容类型

• 期刊论文 [424]
• 学位论文 [8]
• 会议论文 [5]

发表日期

• 2024 [2]
• 2023 [13]
• 2022 [44]
• 2021 [50]
• 2020 [45]
• 2019 [39]
• 更多

学科主题

• Oncology [15]
• Biochemist... [6]
• Cell Biolo... [6]
• Science & ... [5]
• Chemistry [3]
• Pharmacolo... [3]
• 更多

筛选

浏览/检索结果: 共437条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers 期刊论文  OAI收割 CANCER LETTERS, 2024, 卷号: 582, 页码: 15 作者:  Lu, Xuxiu;  Yu, Rilei;  Li, Zhen;  Yang, Mengke;  Dai, Jiajia   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/07 Acquired resistance  Cancer  NSCLC  JC-010a  SHP2   Diastereomers of Steroidal Alkaloids with Cytotoxic Activities against Non-Small-Cell Lung Cancer from the Bulbs of Fritillaria sinica 期刊论文  OAI收割 JOURNAL OF NATURAL PRODUCTS, 2024, 卷号: 87, 期号: 2, 页码: 252-265 作者:  Li, Jia-yuan;  Wu, Shi-fei;  An, Ya-ling;  Yao, Chang-liang;  Yao, Shuai   |  收藏  |  浏览/下载：99/0  |  提交时间：2024/03/13 Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12 作者:  Lin, Ting-ting;  Xiong, Wei;  Chen, Gui-hua;  He, Yang;  Long, Li   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/01/26 osimertinib resistance  targeted drug delivery  liposomes  panobinostat  tumor-associated macrophage  combination therapy   From bench to bedside: current development and emerging trend of KRAS-targeted therapy 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 18 作者:  Chen, Yi;  Liu, Qiu-pei;  Xie, Hua;  Ding, Jian   |  收藏  |  浏览/下载：27/0  |  提交时间：2024/01/16 KRAS mutation  KRAS(G12C) inhibitor  Pan-KRAS inhibitor  SHP2 allosteric inhibitor  SOS1 inhibitor  combination therapy   A validated LC-MS/MS method for the quantification of bevacizumab in rat, cynomolgus monkey, and human serum 期刊论文  OAI收割 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 卷号: 235, 页码: 11 作者:  Zhou, Ainan;  Yu, Jinghua;  Wu, Yali;  Xue, Hao;  Zhong, Dafang   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/10/17 Monoclonal antibody  Bevacizumab  LC-MS  MS  Surrogate peptide  Pharmacokinetics  Serum   Perfluoro-tert-butyl Group-Derived Capmatinib: Synthesis, Biological Evaluation and Its Application in F-19 Magnetic Resonance Imaging 期刊论文  OAI收割 CHEMBIOCHEM, 2023, 页码: 9 作者:  Zhang, Xinnan;  Wang, Luting;  Huang, Ruimin;  Wang, Jingbo;  Yan, Qifan   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 F-19 MRI  Capmatinib derivatives  Targeted imaging  Fluorinated derivatization  Bioimaging   Efficacy of Near-Infrared Fluorescence Video-Assisted Thoracoscopic Surgery for Small Pulmonary Nodule Resection with Indocyanine Green Inhalation: A Randomized Clinical Trial 期刊论文  OAI收割 ANNALS OF SURGICAL ONCOLOGY, 2023, 页码: 11 作者:  Wang, Kun;  Huang, Weiyuan;  Chen, Xianshan;  Li, Gao;  Li, Na   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/11/17 SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 13 作者:  Zhou, Ji;  Zhang, Xu-Chao;  Xue, Shan;  Dai, Mengdi;  Wang, Yueliang   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 Covalent inhibitor targets KRasG12C: A new paradigm for drugging the undruggable and challenges ahead 期刊论文  OAI收割 GENES & DISEASES, 2023, 卷号: 10, 期号: 2, 页码: 403-414 作者:  Li, Hui-yu;  Qi, Wei-liang;  Wang, Yu-xiang;  Meng, Ling-hua   |  收藏  |  浏览/下载：117/0  |  提交时间：2023/10/17 Biomarkers  Covalent KRasG12Cinhibitors  Drug resistance  Human cancers  KRASG12Cmutation   Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor 期刊论文  OAI收割 MOLECULAR PHARMACEUTICS, 2023, 卷号: 20, 期号: 2, 页码: 1394-1403 作者:  Cao, Rui;  Li, Renda;  Shi, Hui;  Liu, Hongguang;  Cheng, Zhen   |  收藏  |  浏览/下载：3/0  |  提交时间：2024/03/27 NIR-II  peptide  HER2  tumor  optical imaging